Vamikibart
伐米奇拜单抗
Report date: 2024/05/20 16:19:31
Base Information
Drug NameVamikibart
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[26]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSesen Bio Inc
China Registration ClassN/A
Develop Information
Active CompaniesF. Hoffmann-La Roche LtdGenentech IncRoche (China) Holding Ltd
Inactive CompaniesEleven Biotherapeutics Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A